Register or Login
  • All
  • Uniprot Id
  • Catalog #
  • Peptide Sequence
>   home   >   Products   >   Peptides   >   Blocking Peptides   >   HNRNPA1L2 Blocking Peptide (N-Term)   

HNRNPA1L2 Blocking Peptide (N-Term)

Synthetic peptide

Product Information
Primary Accession Q32P51
Additional Information
Other Names Heterogeneous nuclear ribonucleoprotein A1-like 2, hnRNP A1-like 2, hnRNP core protein A1-like 2, HNRNPA1L2, HNRNPA1L
Target/Specificity The synthetic peptide sequence is selected from aa 22-36 of HUMAN HNRNPA1L2
Format Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
StorageMaintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.
PrecautionsThis product is for research use only. Not for use in diagnostic or therapeutic procedures.
Protein Information
Synonyms HNRNPA1L
Function Involved in the packaging of pre-mRNA into hnRNP particles, transport of poly(A) mRNA from the nucleus to the cytoplasm and may modulate splice site selection.
Cellular Location Nucleus. Cytoplasm. EMBL; AK123159; -; NOT_ANNOTATED_CDS; mRNA EMBL; AL137058; -; NOT_ANNOTATED_CDS; Genomic_DNA EMBL; CH471124; EAW52041.1; -; Genomic_DNA EMBL; BC108266; AAI08267.1; -; mRNA CCDS; CCDS31980.1; - RefSeq; NP_001011724.1; NM_001011724.1 RefSeq; NP_001011725.1; NM_001011725.1 SMR; Q32P51; - BioGRID; 126887; 44 IntAct; Q32P51; 58 MINT; Q32P51; - STRING; 9606.ENSP00000350090; - iPTMnet; Q32P51; - PhosphoSitePlus; Q32P51; - SwissPalm; Q32P51; - BioMuta; HNRNPA1L2; - DMDM; 190356061; - EPD; Q32P51; - jPOST; Q32P51; - MassIVE; Q32P51; - MaxQB; Q32P51; - PaxDb; Q32P51; - PeptideAtlas; Q32P51; - PRIDE; Q32P51; - ProteomicsDB; 61627; - Antibodypedia; 35162; 31 antibodies Ensembl; ENST00000357495; ENSP00000350090; ENSG00000139675 GeneID; 144983; - KEGG; hsa:144983; - UCSC; uc021rjy.3; human CTD; 144983; - EuPathDB; HostDB:ENSG00000139675.11; - GeneCards; HNRNPA1L2; - HGNC; HGNC:27067; HNRNPA1L2 HPA; ENSG00000139675; Low tissue specificity neXtProt; NX_Q32P51; - PharmGKB; PA164720701; - eggNOG; KOG0118; Eukaryota GeneTree; ENSGT00950000183123; - HOGENOM; CLU_012062_1_0_1; - InParanoid; Q32P51; - KO; K12741; - OMA; MGAYGRA; - OrthoDB; 1202220at2759; - PhylomeDB; Q32P51; - TreeFam; TF351342; - PathwayCommons; Q32P51; - BioGRID-ORCS; 144983; 71 hits in 841 CRISPR screens ChiTaRS; HNRNPA1L2; human GenomeRNAi; 144983; - Pharos; Q32P51; Tdark PRO; PR:Q32P51; - Proteomes; UP000005640; Chromosome 13 RNAct; Q32P51; protein Bgee; ENSG00000139675; Expressed in small intestine Peyer's patch and 162 other tissues ExpressionAtlas; Q32P51; baseline and differential Genevisible; Q32P51; HS GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell GO; GO:0005634; C:nucleus; IBA:GO_Central GO; GO:1990904; C:ribonucleoprotein complex; IBA:GO_Central GO; GO:0005681; C:spliceosomal complex; IEA:UniProtKB-KW GO; GO:0003729; F:mRNA binding; IBA:GO_Central GO; GO:0003723; F:RNA binding; IBA:GO_Central GO; GO:0006397; P:mRNA processing; IEA:UniProtKB-KW GO; GO:0051028; P:mRNA transport; IEA:UniProtKB-KW GO; GO:0051252; P:regulation of RNA metabolic process; IBA:GO_Central GO; GO:0008380; P:RNA splicing; IEA:UniProtKB-KW CDD; cd12580; RRM2_hnRNPA1; 1 Gene3D;; -; 2 InterPro; IPR021662; HnRNPA1 InterPro; IPR034803; hnRNPA1_RRM2 InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf InterPro; IPR035979; RBD_domain_sf InterPro; IPR000504; RRM_dom Pfam; PF11627; HnRNPA1; 1 Pfam; PF00076; RRM_1; 2 SMART; SM00360; RRM; 2 SUPFAM; SSF54928; SSF54928; 2 PROSITE; PS50102; RRM; 2 2: Evidence at transcript level; Acetylation; Cytoplasm; Methylation; mRNA processing; mRNA splicing; mRNA transport; Nucleus; Phosphoprotein; Polymorphism; Reference proteome; Repeat; Ribonucleoprotein; RNA-binding; Spliceosome; Transport CHAIN 1..320 /note="Heterogeneous nuclear ribonucleoprotein A1-like 2" /id="PRO_0000318848" DOMAIN 14..97 /note="RRM 1" /evidence="ECO:0000255|PROSITE-ProRule:PRU00176" DOMAIN 105..184 /note="RRM 2" /evidence="ECO:0000255|PROSITE-ProRule:PRU00176" REGION 4..94 /note="Globular A domain" REGION 95..185 /note="Globular B domain" REGION 218..240 /note="RNA-binding RGG-box" REGION 268..305 /note="Nuclear targeting sequence" /evidence="ECO:0000250" COMPBIAS 195..317 /note="Gly-rich" MOD_RES 6 /note="Phosphoserine" /evidence="ECO:0000250|UniProtKB:P49312" MOD_RES 22 /note="Phosphoserine" /evidence="ECO:0000250|UniProtKB:P49312" MOD_RES 194 /note="Asymmetric dimethylarginine; alternate" /evidence="ECO:0000250|UniProtKB:P09867" MOD_RES 194 /note="Omega-N-methylarginine; alternate" /evidence="ECO:0000250|UniProtKB:P49312" MOD_RES 206 /note="Asymmetric dimethylarginine; alternate" /evidence="ECO:0000250|UniProtKB:P49312" MOD_RES 206 /note="Omega-N-methylarginine; alternate" /evidence="ECO:0000250|UniProtKB:P49312" MOD_RES 218 /note="Asymmetric dimethylarginine; alternate" /evidence="ECO:0000250|UniProtKB:P49312" MOD_RES 218 /note="Omega-N-methylarginine; alternate" /evidence="ECO:0000250|UniProtKB:P49312" MOD_RES 225 /note="Asymmetric dimethylarginine; alternate" /evidence="ECO:0000250|UniProtKB:P49312" MOD_RES 225 /note="Omega-N-methylarginine; alternate" /evidence="ECO:0000250|UniProtKB:P49312" MOD_RES 284 /note="Omega-N-methylarginine" /evidence="ECO:0000250|UniProtKB:P49312" MOD_RES 298 /note="N6-acetyllysine" /evidence="ECO:0000250|UniProtKB:P49312" VARIANT 215 /note="N -> D (in dbSNP:rs9536212)" /id="VAR_038904" CONFLICT 289 /note="Y -> C (in Ref. 4; AAI08267)" /evidence="ECO:0000305" SEQUENCE 320 AA; 34225 MW; 002EE1547DAC04A2 CRC64; MSKSASPKEP EQLRKLFIGG LSFETTDESL RSHFEQWGTL TDCVVMRDPN TKRSRGFGFV TYATVEEVDA AMNTTPHKVD GRVVEPKRAV SREDSQRPGA HLTVKKIFVG GIKEDTEEHH LRDYFEQYGK IEVIEIMTDR GSGKKRGFAF VTFDDHDSVD KIVIQKYHTV KGHNCEVRKA LPKQEMASAS SSQRGRRGSG NFGGGRGDGF GGNDNFGRGG NFSGRGGFGG SCGGGGYGGS GDGYNGFGND GSNFGGGGSY NDFGNYNNQS SNFGPMKGGN FGGRSSGPYG GGGQYFAKPQ NQGGYGVSSS SSSYGSGRRF
Research Areas
Citations (0)

Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.

Submit your citation using an Abcepta antibody to, and receive a free "I Love Antibodies" mug.


Involved in the packaging of pre-mRNA into hnRNP particles, transport of poly(A) mRNA from the nucleus to the cytoplasm and may modulate splice site selection.


Ota T.,et al.Nat. Genet. 36:40-45(2004).
Dunham A.,et al.Nature 428:522-528(2004).
Mural R.J.,et al.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.

Abcepta welcomes feedback from its customers.

If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.

If you have any additional inquiries please email technical services at

$ 277.78
Cat# BP21634a
Availability: 2 weeks
Bulk Size

Ordering Information

United States
AlbaniaAustraliaAustriaBelgiumBosnia & HerzegovinaBrazilBulgariaCanadaCentral AmericaChinaCroatiaCyprusCzech RepublicDenmarkEstoniaFinlandFranceGermanyGreeceHong KongHungaryIcelandIndiaIndonesiaIrelandIsraelItalyJapanLatviaLithuaniaLuxembourgMacedoniaMalaysiaMaltaNetherlandsNew ZealandNorwayPakistanPolandPortugalRomaniaSerbiaSingaporeSlovakiaSloveniaSouth AfricaSouth KoreaSpainSwedenSwitzerlandTaiwanTurkeyUnited KingdomUnited StatesVietnamWorldwideOthers
Abcepta, Inc.
(888) 735-7227 / (858) 622-0099
(858) 622-0609
USA Headquarters
(888) 735-7227 / (858) 622-0099 or (858) 875-1900
Cedarlane Labs
+1 (800) 721-1644
+1 (336) 513-5138

Shipping Information

Domestic orders (in stock items)
Shipped out the same day. Orders placed after 1 PM (PST) will ship out the next business day.
International orders
Contact your local distributors
Terms & Conditions